It's hoped new research into type-1-diabetes could spell an end to patients' life-long need for daily needle treatment. Scientists have identified a crucial hybrid peptide that could unlock the mystery of why the immune system kills insulin-producing cells.
It's hoped new research into type-1-diabetes could spell an end to patients' life-long need for daily needle treatment. Scientists have identified a crucial hybrid peptide that could unlock the mystery of why the immune system kills insulin-producing cells.
